Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
EdgeCore Digital Infrastructure $1.9 billion project financing
We advised Edgecore and its owner, Partners Group, on the transaction
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Myers Industries $350 million acquisition of Signature Systems
We are advising Myers Industries on the acquisition
Air Methods emerges from chapter 11
We advised the ad hoc group that negotiated and backstopped the restructuring
Cadeler combination with Eneti
We advised Cadeler on the transaction
Williams $1.95 billion acquisition of natural gas storage assets from Hartree
We are advising Williams on the acquisition
HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
GSK exclusive license agreement for HS-20093 with Hansoh Pharma
We advised GSK on the transaction
MSCI acquisition of Fabric RQ
We are advising MSCI on the acquisition